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The use of mesenchymal stem cells (MSCs) has emerged as 
a potential new treatment for myocardial infarction. 
However, the poor viability of MSCs after transplantation 
critically limits the efficacy of this new strategy. The 
expression of microRNA-210 (miR-210) is induced by 
hypoxia and is important for cell survival under hypoxic 
conditions. Hypoxia increases the levels of hypoxia inducible 
factor-1 (HIF-1) protein and miR-210 in human MSCs 
(hMSCs). miR-210 positively regulates HIF-1α  activity. 
Furthermore, miR-210 expression is also induced by 
hypoxia through the regulation of HIF-1α . To investigate 
the effect of miR-210 on hMSC survival under hypoxic 
conditions, survival rates along with signaling related to cell 
survival were evaluated in hMSCs over-expressing miR-210 
or ones that lacked HIF-1α expression. Elevated miR-210 
expression increased survival rates along with Akt and ERK 
activity in hMSCs with hypoxia. These data demonstrated 
that a positive feedback loop involving miR-210 and HIF-1α  
was important for MSC survival under hypoxic conditions.
Keywords: cell survival, human mesenchymal stem cells, 
hypoxia, hypoxia inducible factor-1, microRNA-210
Introduction
　Bone marrow-derived mesenchymal stem cells (MSCs) are 
an excellent model for developing cell-based therapeutics 
because of their potential for repairing damaged tissue. In 
particular, MSCs possess advantageous attributes such as 
ease of isolation, high expansion potential, genetic stability, 
and multipotent capacity. For these reasons, MSCs have 
emerged as the most suitable candidate for cellular therapy 
and tissue engineering techniques. Several preclinical 
studies have demonstrated that MSCs help prevent 
deleterious ventricular remodeling and improve the recovery 
of cardiac performance after myocardial infarction [23,31]. 
However, Toma et al. [34] reported a very low survival rate 
(＜1%) of MSCs transplanted into ischemic hearts 4 days 
after transplantation. Poor MSC viability after 
transplantation critically limits the efficacy of this new 
therapeutic strategy [23,25,31].
　A major challenge to stem cell therapy is that transplanted 
stem cells undergo apoptosis at an accelerated rate given that 
they are exposed to an extremely harsh, pro-apoptotic 
microenvironment in the injured region [10]. In addition to a 
poor blood supply and low oxygen tension, inflammation 
triggered by tissue damage may generate oxidative stress as 
well as cytotoxic radicals and proteins, all of which may 
cause the death of transplanted cells through several 
different mechanisms including apoptosis [10]. In particular, 
hypoxia, defined as an insufficient oxygen supply to tissues, 
can result from physiological or pathological conditions and 
changes the physiological characteristics of embryonic and 
adult stem cells [6]. The mechanism underlying hypoxic 
condition might be primarily attributed to the hypoxia 
70    Woochul Chang et al.
inducible factor-1 (HIF-1) signal pathway [37]. HIFs control 
cellular responses to hypoxia by regulating genes that are 
involved in metabolism, angiogenesis, erythropoiesis, cell 
proliferation, differentiation, and apoptosis [13]. HIF is a 
heterodimer consisting of an oxygen-sensitive alpha subunit 
(HIFα) and a constitutively active beta subunit (HIF-1β; aryl 
hydrocarbon receptor nuclear translocator). Three isoforms 
of HIFα have been identified. HIF-1α and HIF-2α are 
thought to modulate the majority of responses to hypoxia 
involving HIFα [21]. In the presence of hypoxia, stabilized 
HIFα binds to HIF-1β, and the resulting complex regulates 
the expression of downstream genes involved in adaptation 
to and protection against low oxygen levels [21].
　MicroRNA (miRNA) consists of single-stranded 
noncoding RNA containing 19-23 nucleotides that 
mechanistically influences a variety of cellular functions 
via translational inhibition or degradation of target mRNA. 
Given the diverse roles of miRNA in numerous cellular 
functions, the role of this molecule in gene regulation 
associated with hypoxia is not surprising. Recently, 
miRNA molecules have emerged as a new class of genes 
regulated by HIF-1α in response to hypoxia. miRNA-199a 
(miR-199a), miR-17-92 clusters, and miR-20b regulate 
HIF-1α with hypoxia [19,29,32] whereas the expression of 
miR-23, miR-24, miR-26, miR-107, miR-210, and 
miR-373 is induced by HIFs [5,12]. Following the first 
report of hypoxia affecting miRNA expression by Ivan and 
colleagues in 2007 [18], a number of studies have 
demonstrated that miR-210 is the most consistently and 
predominantly up-regulated miRNA in hypoxic condition. 
In cancer cells, miR-210 over-expression under normoxic 
conditions leads to increased HIF-1α levels [13]. 
Consequently, HIF-1α activity increases, triggering the 
accumulation of miR-210 as oxygen levels decrease. 
Increased miR-210 levels suppress the protein expression 
of glycerol-3-phosphate dehydrogenase 1-like (GPD1L) 
as a negative regulator of HIF-1α stability and a direct 
target of miR-210, resulting in increased activity of 
HIF-1α [14,28].
　In the present study, we hypothesized that the positive 
feedback loop between miR-210 and HIF-1α would 
improve the survival of human MSCs (hMSCs) under 
hypoxic conditions. To test this hypothesis, we confirmed 
the induction of HIF-1α and miR-210 expression in hypoxic 
hMSCs. We also determined that HIF-1α and miR-210 
mutually regulated each other’s activities when miR-210 
was over-expressed and HIF-1α was down-regulated in 
MSCs. Moreover, miR-210 overexpression regulated cell 
survival and modulated HIF-1 activity.
Materials and Methods
Materials
　Cobalt (II) chloride hexahydrate (CoCl2), Z-Leu-Leu- 
Leu-al (MG132), and anti-β-actin antibody were purchased 
from Sigma-Aldrich (USA). Anti-HIF-1α antibody (H-206) 
was obtained from Santa Cruz Biotechnology (USA). 
Anti-phospho-Akt, Akt, anti-phospho-ERK1/2, and 
ERK1/2 antibodies were obtained from Cell Signaling 
(USA).
hMSC culturing
　hMSCs (cat. No. PT-2501) were obtained from Lonza 
(USA). The cells had been harvested from normal human 
bone marrow and were maintained at 37oC humidified 
atmosphere containing 5% CO2 incubator. Culture media 
composed 10% fetal bovine serum (FBS; Invitrogen, USA) 
Dulbecco’s modified Eagle’s medium (DMEM)-low 
glucose supplemented with and 100 U/mL penicillin 
(Invitrogen, USA) and 100 μg/mL streptomycin (Invitrogen, 
USA). Fresh media was added and replaced every 3 or 4 
days. We used the hMSCs after 7∼10 passages. At these 
passage numbers, hMSCs maintained a consistent 
morphology and were positive for various mesenchymal 
markers such as CD29, 44, 105, and 166 by flow cytometry 
(data not show).
Experimental induction of hypoxia
　MSCs were cultured until 80% confluent and were then 
grown under hypoxic conditions for 12∼24 h. The 
medium used for culturing under hypoxic conditions was 
serum-free DMEM containing 100 U/mL penicillin and 
100 μg/mL streptomycin. The medium was degassed and 
then exposed to a gas mixture of 5% CO2, 10% H2, and 
85% N2. The hypoxic cells were maintained in an airtight 
humidified hypoxic chamber (Anaerobic Environment; 
ThermoForma, USA) at 37oC and continuously gassed 
with 85% N2. Cobalt chloride (CoCl2; Sigma, USA) was 
dissolved in PBS and used at a final concentration of 250 
μM in serum-free DMEM under normoxic conditions for 
24 h.
miRNA transfection
　miRNA was purchased from Genolution Pharmaceuticals 
(Korea). hMSCs were transfected with the miRNA at a final 
concentration of 100 nM using siLentFect Lipid reagent 
(Bio-Rad, USA) in serum free DMEM. miR-210 mimic, 
chemically optimized double-stranded RNA, or scrambled 
RNA oligomer was transfected into cells. After transfection 
for 4 h, the media were replaced in 10% FBS contained 
DMEM.
Real-time PCR
　MSCs were lysis using 1 mL TRIzol reagent (Sigma, USA). 
Total RNA was extracted using chloroform (200 μL) and 
shaked vigorously for 15 sec and incubate at room 
temperature for 7 min. Next, centrifugation at 12,000 × g, at 
4oC for 15 min, caused three layers to appear, and the 
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transparent upper aqueous phase was collected in a new tube. 
Each sample next received 500 μL 2-propanol, and inverted 
for 10 sec was repeated and centrifugation at 12,000 × g, at 
4oC for 10 min. The pellet washed in diethylpyrocarbonate- 
contained 75% ethanol. Centrifugation at 7,500 × g, at 4oC 
for 5 min, followed. Remove all leftover ethanol and pellet 
dried about 2 min at room temperature. The isolated RNA 
was resuspended in 30 μL nuclease-free water. The quantity 
and quality of the RNA were determined by measuring the 
OD260/280 ratio with a DU 640 spectrophotometer 
(Eppendorf, Germany). Next, 100 ng the purified total RNA 
underwent reverse transcription (Taqman MicroRNA 
Reverse Transcriptase kit; Applied Biosystems, USA) in 
combination Taqman MicroRNA assays. The threshold 
cycle (Ct) of each target gene was automatically defined, 
located in the linear amplification phase of the PCR, and 
normalized to control U6 (ΔCt value). The relative 
difference in expression levels of each miRNAs was 
calculated (DDCt) and is reported as fold induction (2-ΔΔCt). 
Amplification and detection of miR-210 or U6 were 
performed using a TaqMan Small RNA Assay kit (Applied 
Biosystems, USA) at 95oC for 10 min followed by 40 cycles 
of 95oC for 15 sec and 60oC for 60 sec in a Light Cycler 480 
II (Roche, Switzerland). The threshold cycle (Ct) of each 
target gene was automatically identified in the linear 
amplification phase of PCR and normalized to the cycle 
number of the RNU19 control (ΔCt value). Relative 
differences in the expression levels of each miRNA 
sequence were calculated (ΔΔCt) and reported as 
fold-induction (2-ΔΔCt). The hsa-miRNA primer was: 
miR-210 5´ CUGUGCGUGUGACAGCGGCUGA 3´.
HIF-1α small interfering RNA (siRNA) production 
and transfection
　Single-stranded siRNA specific for human HIF-1α 
(si-HIF-1α) was synthesized by Bioneer (Korea). 
Sequence of the oligonucleotide was as follows: 5´ 
AGAGGUGGAUAUGUGUGGGdTdT 3´. For transfection, 
hMSCs were grown to 80% confluence in 10% FBS 
contained DMEM at 37oC incubator and then transfected 
with HIF-1α siRNA using Oligofectin (Invitrogen, USA). 
Briefly, si-HIF-1α was added to hMSCs at a final 
concentration of 100 nM in 10% FBS contained DMEM 
without antibiotics. After transfection for 4 h, the media 
were replaced in 10% FBS contained DMEM with 
antibiotics.
Western blotting analysis
　hMSCs were lysed in lysis buffer containing 
phosphate-buffered saline containing 1% Triton X-100, 10× 
protease inhibitor cocktail (Roche, Switzerland), 1 mM 
phenylmethylsulfonyl fluoride (Thermo Fisher Scientific, 
USA), and 60 nM MG132 at 4oC for 30 min. Protein 
concentrations were measured using the Bradford Protein 
Assay Kit (Bio-Rad, USA). The protein samples (60 μg) 
were then subjected to 10% sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. The separated 
proteins were transferred onto polyvinylidene fluoride 
membranes (EMD Millipore, USA) at 100 mV and 135 mA 
for 2 h by Power supply (Bio-Rad, USA). The membranes 
were blocked in Tris-buffered saline-0.1% Tween 20 
(TBST) containing 10% nonfat dried milk for 1 h at room 
temperature or overnight (O/N) at 4oC. Next, the 
membranes were incubated with 1 : 1,000 anti-HIF-1α, 1：
4,000 anti-β-actin, 1：1,000 anti-phospho-Akt, 1：1,000 
Akt, 1 : 1,000 anti-phospho-ERK1/2, and 1 : 1,000 ERK1/2 
antibodies for 1 h at room temperature or O/N at 4oC. The 
blots were washed in 1× TBST three times at room 
temperature and subsequently incubated with 1：4,000 
horseradish peroxidase-conjugated   secondary antibody 
against mouse or rabbit (Santa Cruz Biotechnology, USA) 
for 1 h at room temperature. After washing the membranes 
six times using TBST, immunoreactive proteins were 
detected using an enhanced chemiluminescence (ECL) 
system (Amersham Biosciences, UK). ImageJ software 
(National Institutes of Health, USA) was used for band 
intensity quantification. 
Cell viability assay
　Cell viability was determined with a CCK-8 [2-(2- 
methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfo
phenyl)-2H-tetrazolium, monosodium salt] assay kit 
(Dojindo, Japan). hMSCs (5 × 103 cells per well) were 
plated in triplicate wells in 96-well plates (Corning, USA) 
and incubated for 24 h. The cells were transfected with 
miR-210 mimic and incubated in a hypoxic chamber for 
24 h. The CCK-8 assay kit was diluted with 0.1% FBS 
contained DMEM and then 100 μL was added to each well 
and incubated for 2 h at 37oC. The cells were incubated at 
37oC for 2 h. Absorbance was then measured at 450 nm 
with a spectrophotometer (Bio-Rad, USA).
Statistical analysis
　Data are expressed as the mean ± SE. Differences 
between groups were assessed by Student’s t-test. 
Comparisons between more than two groups were made 
with a one-way ANOVA using Bonferroni correction. 
P-values less than 0.05 were considered significant.
Results
Expression of HIF-1α and miR-210 correlates with 
hypoxia and CoCl2 treatment
　The activity of HIF-1α and miR-210 expression is 
increased by hypoxia. We first confirmed that HIF-1α was 
expressed in hMSCs under hypoxic conditions and with 
CoCl2 treatment using a Western blot. HIF-1α expression 
was up-regulated after CoCl2 treatment or with oxygen 
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Fig. 1. Expression of hypoxia inducible factor (HIF)-1α in 
human mesenchymal stem cells (hMSCs) under hypoxic 
conditions. hMSCs were treated with 250 μM CoCl2 for 24 h and
incubated in a hypoxic chamber for 24 h. (A) Expression of 
HIF-1α was detected by immunoblotting. (B) The ratio of 
HIF-1α to β-actin band density values. Results are expressed as 
the mean ± SE for three independent experiments performed in 
triplicate. *p ＜ 0.01 and **p ＜ 0.05 vs. the control.
Fig. 2. Expression of microRNA-210 (miR-210) with hypoxia or
CoCl2 treatment. miR-210 expression was measured by real-time
PCR. Expression of endogenous miR-210 was detected under 
hypoxic conditions over time or in the presence with 250 μM 
CoCl2 for 24 h. Results are expressed as the mean ± SE for three
independent experiments performed in triplicate. *p ＜ 0.01 and 
**p ＜ 0.05 vs. the control.
Fig. 3. Effect of miR-210 over-expression on HIF-1α protein 
stability in hMSCs. (A) Transfection efficiency of the miR-210 
mimic was monitored by real-time PCR. (B) Expression of 
HIF-1α was detected by immunoblotting. Cells transfected with 
the miR-210 mimic were incubated under normoxic or hypoxic 
conditions. Results are expressed as the mean ± SE for three 
independent experiments performed in triplicate. *p < 0.01 and 
**p ＜ 0.05 vs. the control.
deprivation (Fig. 1). Until 24 h of hypoxia, HIF-1α 
expression increased compared to control. To detect 
miR-210 transcription, we examined changes in miR-210 
transcript levels in the presence of CoCl2 or under hypoxic 
conditions. Changes in miR-210 transcription were the 
same as those observed for HIF-1α under the same 
experimental conditions (Fig. 2). Taken together, these 
data indicate that long-term exposure to hypoxia results in 
decreased HIF-1α and miR-210 expression.
Positive feedback loop of miR-210 and HIF-1α    73
Fig. 4. Effect of HIF-1α down-regulation on the induction of 
miR-210 expression under hypoxic conditions. hMSCs were 
transfected with HIF-1α-specific small interfering RNA 
(si-HIF-1α) at a final concentration of 100 nM and incubated in 
a hypoxia chamber for 12 h. (A) Expression of HIF-1α and β-actin was detected by immunoblotting. (B) miR-210 
expression was measured by real-time PCR. Results are 
expressed as the mean ± SE for three independent experiments 
performed in triplicate. *p ＜ 0.01 vs. the control.
Fig. 5. Effect of miR-210 and HIF-1α on the survival of hypoxic 
hMSCs. After transfection with the miR-210 mimic, the survival
of hMSCs was measured with a CCK-8 assay. Data presented a 
typical experiment conducted more than three times. Results are
expressed as the mean ± SE. *p ＜ 0.01 and **p ＜ 0.05 vs. the 
control.
miR-210 positively regulates HIF-1α activity
　To investigate the role of miR-210 in regulating HIF-1α 
expression, hMSCs were transfected with miR-210. 
Transfection efficiency was determined by real-time PCR 
(Fig. 3A). As shown in Fig. 3B, miR-210 overexpression 
induced HIF-1α expression under normoxic conditions 
and restored the expression of HIF-1α 24 h after hypoxia. 
These data suggested that an important function of 
miR-210 is to induce the protein expression of HIF-1α 
with normoxia and that this function is maintained during 
hypoxia.
miR-210 expression is strongly induced by HIF-1α
　We investigated the link between miR-210 and HIF-1α 
up-regulation in hypoxic hMSCs. We successfully 
obliterated HIF-1α expression in hMSCs using siRNA. 
miR-210 overexpression enhanced HIF-1α protein levels 
in hypoxic hMSCs (Fig. 4). Furthermore, hypoxic 
conditions failed to induce miR-210 expression in the 
hMSCs with a concomitant loss of HIF-1α. Taken 
together, these results suggested a positive feedback loop 
between miR-210 and HIF-1α in hypoxic hMSCs.
Survival of hypoxic hMSCs transfected with 
miR-210
　To further evaluate the effect of miR-210 and HIF-1α on 
the survival of hypoxic hMSCs, we transfected hMSCs 
with miR-210 mimics and siRNA specific for HIF-1α. The 
cells were then maintained under hypoxic conditions. 
Survival was measured with a CCK-8 assay. After 24 h of 
incubation with hypoxia, cell death was reduced in the 
miR-210-transfected cells compared to the other groups 
(Fig. 5). We also observed greater phosphorylation of Akt 
and ERK1/2 in the miR-210-transfected hMSCs under 
hypoxic conditions. Moreover, survival rate was 
significantly reduced in hMSCs transfected with siRNA 
specific for HIF-1α (Fig. 6). 
　Based on our results, we proposed a model in which 
HIF-1α induces miR-210 expression that in turn 
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Fig. 6. Effect of miR-210 and HIF-1α on cell survival-related signaling in hypoxic hMSCs. Anti-apoptotic signaling was detected by
immunoblotting. Cells were incubated under hypoxic conditions for 24 h. Results are expressed as the mean ± SE for three independent
experiments performed in triplicate. *p ＜ 0.01 and **p ＜ 0.05 vs. the control.
Fig. 7. Relationship between HIF-1α and miR-210 under 
hypoxic conditions. The relation of HIF-1α and miR-210 results 
in a positive feedback regulatory loop. As shown in this figure, 
miR-210 acts to induce and maintain the expression of HIF-1α
protein. CASP8AP2: caspase 8-associated protein 2. 
increases the stability of HIF-1α. This positive feedback 
loop helps to increase HIF-1α levels during low-oxygen 
conditions and results in increased hMSC survival under 
hypoxic conditions through enhanced phosphorylation 
of Akt and ERK1/2 (Fig. 7).
Discussion
　In the present study, we demonstrated the protective 
effect of miR-210 and HIF-1α in hypoxic hMSCs. Based 
on our findings, we suggest that a positive feedback loop 
involving these factors results in increased survival of 
hMSCs cultured under hypoxic conditions via Akt and 
ERK signaling. MSCs, which are multipotent stromal 
cells, have been isolated from various adult tissues such as 
born marrow, adipose tissue, muscle, and synovial 
membrane [24]. MSCs are capable of self-renewal and 
differentiation into multiple cell lineages [3,24,27]. 
Because of these capacities, MSCs have emerged as the 
most suitable candidates for use in cell-based therapy and 
tissue engineering. Despite interest in the clinical 
applications of MSCs, therapeutic techniques using these 
cells are limited because of poor MSC viability after cell 
transplantation. Thus, genetic modification to protect 
MSCs from apoptosis resulting from hypoxic conditions is 
necessary to improve the efficacy of MSC-based therapy.
　miRNA is endogenous noncoding RNA that down- 
regulates gene expression by translational inhibition or 
degradation of target mRNA. The discovery of miRNA 
resulted in a paradigm shift in the way we view the role of 
RNA in regulating gene expression [1,7]. miRNA acts in a 
complex functional network in which each miRNA 
probably controls hundreds of distinct target genes and the 
expression of a single coding gene can be regulated by 
several miRNA molecules [20,22]. miRNA is made in a 
multi-step process. First, primary miRNA (pri-miRNA) 
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transcripts are produced by RNA polymerase II in the 
nucleus. pri-miRNA is then transformed into hairpin 
precursors (pre-miRNA). The pre-miRNA is transported 
from the nucleus to cytoplasm where it is processed by 
Dicer to form mature single-stranded miRNA. Finally, a 
single strand is preferentially loaded into the core binding 
RNA-induced silencing complex. miRNA binds directly to 
the 3’-untranslated region of specific mRNA transcripts 
through complete or partial complementary pairing to 
induce silencing or direct cleavage of the mRNA. Recent 
evidence shows the important role of miRNA in regulating 
a multitude of physiological functions such as stem cell 
differentiation, neurogenesis, hematopoiesis, immune 
responses, skeletal and cardiac muscle development, and 
stress [4,9,11,16,17,26,33,36].
　Induction of HIF-1α expression constitutes an integral 
part of the cellular response to hypoxia. Moreover, HIF-1α 
serves as a master regulator that orchestrates the 
expression of genes and helps cells adapt to low oxygen 
tension. HIF-1α translocates into the nucleus under 
hypoxic conditions to form a functional complex [30]. 
With a better understanding of gene regulation by 
transcription factors with the participation of miRNA, a 
novel relationship has been established between hypoxia 
and a select group of miRNA.
　The expression of several miRNA transcripts has been 
found to be regulated by HIF-1α in response to hypoxia 
Among them, miR-210, a direct transcriptional target of 
HIF-1α, has emerged as a critical element of the cellular 
hypoxia response in a broad variety of cell types ranging 
from cancer cell lines to human umbilical vein endothelial 
cells [8,12,13]. Interestingly, miR-210 expression is 
regulated by both HIF-1α [2,5,12,35] and HIF-2α [8]. 
HIF-1α directly binds to a hypoxia responsive element 
(HRE) on the proximal miR-210 promoter [12]. When the 
miR-210 core promoter is compared across species, the 
HRE is highly conserved, indicating the importance of 
hypoxia in regulating miR-210 expression [13]. Consistent 
with this observation, the induction of miR-210 expression 
with hypoxia is dependent on HIF-1α [5]. miR-210 
modulates hypoxia-induced cell cycle arrest [8,12,18]. 
Recently, miR-210-based gene therapy using mini genes in 
mice has been shown to improve cardiac function in a model 
of myocardial infarction [15]. Ischemic preconditioning 
also augments the survival of stem cells via miR-210 
expression by targeting caspase 8-associated protein 2 [8].
　Despite these findings, our understanding of the 
relationship between miR-210 and HIF-1α in hypoxic 
hMSCs remains limited. The purpose of the present study 
was to examine mechanisms underlying the induction of 
miR-210 expression via HIF-1α and evaluate the effect of 
miR-210 on the survival of hypoxic hMSCs. In conclusion, 
our results have helped increase our understanding about 
the relationship between HIF-1α and miR-210. Findings 
from the current study suggest that the viability of MSCs 
could be enhanced by increasing miR-210 expression 
before transplantation. Our data may serve as a basis for 
developing novel therapeutic modalities for treating 
injured tissues.
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